Literature DB >> 15073686

Association between longer duration of HIV-suppressive therapy and partial recovery of the V gamma 2 T cell receptor repertoire.

Jose Bordon1, Peter S Evans, Nadia Propp, Charles E Davis, Robert R Redfield, C David Pauza.   

Abstract

Human immunodeficiency virus (HIV) infection alters the function and repertoire of peripheral blood gamma delta T cells expressing the V gamma 2/V delta 2 T cell receptor (TCR). A cross-sectional comparison of the V gamma 2 TCR repertoire was performed for 56 HIV-infected subjects, 51 of whom were receiving highly active antiretroviral therapy (HAART), to measure changes in the V gamma 2 TCR repertoire. Longer durations of HAART were associated with partial recovery of the normal TCR repertoire, and recovery was greatest in subjects with complete virus suppression. Changes in the V gamma 2 TCR repertoire are sensitive measures for the effects of HAART and of residual HIV replication.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15073686     DOI: 10.1086/382961

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  26 in total

Review 1.  Immune regulation of gammadelta T cell responses in mycobacterial infections.

Authors:  Zheng W Chen
Journal:  Clin Immunol       Date:  2005-09       Impact factor: 3.969

2.  Interleukin-18 activates Vγ9Vδ2+ T cells from HIV-positive individuals: recovering the response to phosphoantigen.

Authors:  Alanna S Murday; Suchita Chaudhry; C David Pauza
Journal:  Immunology       Date:  2017-05-24       Impact factor: 7.397

3.  The potential role of CD16+ Vγ2Vδ2 T cell-mediated antibody-dependent cell-mediated cytotoxicity in control of HIV type 1 disease.

Authors:  Xuan He; Hua Liang; Kunxue Hong; Haishan Li; Hong Peng; Yangyang Zhao; Manxue Jia; Yuhua Ruan; Yiming Shao
Journal:  AIDS Res Hum Retroviruses       Date:  2013-09-13       Impact factor: 2.205

Review 4.  Lymphocytic choriomeningitis virus (LCMV) infection of macaques: a model for Lassa fever.

Authors:  Juan C Zapata; C David Pauza; Mahmoud M Djavani; Juan D Rodas; Dmitry Moshkoff; Joseph Bryant; Eugene Ateh; Cybele Garcia; Igor S Lukashevich; Maria S Salvato
Journal:  Antiviral Res       Date:  2011-07-27       Impact factor: 5.970

5.  Impact of persistent HIV replication on CD4 negative Vγ2Vδ2 T cells.

Authors:  Sarah Boudová; Haishan Li; Mohammad M Sajadi; Robert R Redfield; C David Pauza
Journal:  J Infect Dis       Date:  2012-03-26       Impact factor: 5.226

6.  Natural viral suppressors of HIV-1 have a unique capacity to maintain gammadelta T cells.

Authors:  David J Riedel; Mohammad M Sajadi; Cheryl L Armstrong; Jean-Saville Cummings; Cristiana Cairo; Robert R Redfield; C David Pauza
Journal:  AIDS       Date:  2009-09-24       Impact factor: 4.177

Review 7.  Depletion and dysfunction of Vγ2Vδ2 T cells in HIV disease: mechanisms, impacts and therapeutic implications.

Authors:  Haishan Li; Suchita Chaudhry; Suchita Chaudry; Bhawna Poonia; Yiming Shao; C David Pauza
Journal:  Cell Mol Immunol       Date:  2012-12-17       Impact factor: 11.530

8.  The γδ T-cell receptor repertoire is reconstituted in HIV patients after prolonged antiretroviral therapy.

Authors:  Suchita Chaudhry; Cristiana Cairo; Vanessa Venturi; C David Pauza
Journal:  AIDS       Date:  2013-06-19       Impact factor: 4.177

9.  Gammadelta T cell immune manipulation during chronic phase of simian-human immunodeficiency virus infection [corrected] confers immunological benefits.

Authors:  Zahida Ali; Lin Yan; Nicholas Plagman; Armin Reichenberg; Martin Hintz; Hassan Jomaa; Francois Villinger; Zheng W Chen
Journal:  J Immunol       Date:  2009-09-28       Impact factor: 5.422

10.  Association between Vgamma2Vdelta2 T cells and disease progression after infection with closely related strains of HIV in China.

Authors:  Haishan Li; Hong Peng; Pengfei Ma; Yuhua Ruan; Bing Su; Xinping Ding; Chen Xu; C David Pauza; Yiming Shao
Journal:  Clin Infect Dis       Date:  2008-05-01       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.